IL32 and prostate cancer: Studies have shown (20) that NK4 is used in the treatment of prostate cancer, The mechanism by which NK4 promotes apoptosis in DU145 cells maybe its inhibitory effect on HGF-induced proliferation, leading to increased apoptosis.